These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2515615)

  • 1. The effect of venous occlusion on the PAI and antiplasmins release from platelets.
    Woods AI; Nadra CA; Lazzari MA
    Thromb Res; 1989 Nov; 56(3):491-5. PubMed ID: 2515615
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasminogen activation system of the platelets.
    Park S
    Rinsho Byori; 1992 Mar; Suppl 92():131-43. PubMed ID: 1583771
    [No Abstract]   [Full Text] [Related]  

  • 3. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis.
    Leebeek FW; Kluft C; Knot EA; de Maat MP; Wilson JH
    Gastroenterology; 1991 Nov; 101(5):1382-90. PubMed ID: 1718809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.
    Sørensen JV
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):43-9. PubMed ID: 7514044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
    Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
    J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulatory mechanisms of PAI-1 on fibrinolysis in vascular endothelial cells].
    Sakata Y
    Rinsho Byori; 1989 Apr; Spec No 81():149-55. PubMed ID: 2502640
    [No Abstract]   [Full Text] [Related]  

  • 7. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA; Booth NA; Croll AM; Bennett B
    Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit.
    Voss R; Matthias FR; Borkowski G; Reitz D
    Br J Haematol; 1990 May; 75(1):99-105. PubMed ID: 1695855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
    J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of fibrinolysis during labour with and without aprotinin application].
    Kühnert M; Stein W; Tekesin I; Hellmeyer L; Schmidt S
    Z Geburtshilfe Neonatol; 2003; 207(3):90-100. PubMed ID: 12891467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator release and plasminogen activator inhibitor levels in coronary artery disease.
    Meyers DG; Haire WD; Rasmussen JK; Boyd EJ
    Angiology; 1991 Jul; 42(7):561-7. PubMed ID: 1907440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers.
    Ozdemir O; Karaaslan Y; Ozcebe O; Dündar S; Kirazli S
    Thromb Res; 1992 Jan; 65(2):263-74. PubMed ID: 1533735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin effect on platelet antiplasmins release.
    Woods AI; Lazzari MA
    Thromb Res; 1987 Aug; 47(3):269-77. PubMed ID: 3629554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.
    Brandtzaeg P; Joø GB; Brusletto B; Kierulf P
    Thromb Res; 1990 Jan; 57(2):271-8. PubMed ID: 2315889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma fibrinolysis during and after normal childbirth.
    Mackinnon S; Walker ID; Davidson JF; Walker JJ
    Br J Haematol; 1987 Mar; 65(3):339-42. PubMed ID: 2436648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells.
    Diamond SL; Eskin SG; McIntire LV
    Science; 1989 Mar; 243(4897):1483-5. PubMed ID: 2467379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of plasminogen activator inhibitor (PAI) activity of human plasma after dilution in a PAI-depleted plasma.
    Contant G; Martinoli JL
    Thromb Res; 1989 Nov; 56(3):377-86. PubMed ID: 2515610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of hemostasis in ischemic cerebrovascular disease. III. Abnormalities in vascular plasminogen activators, antiactivators and alpha 2-antiplasmin.
    Mettinger KL; Egberg N
    Thromb Res; 1982 May; 26(3):203-10. PubMed ID: 6810498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.